Clinical Trial Update: Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating Tripterygium wilfordii Hook F in combination with methotrexate for postmenopausal women with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tripterygium wilfordii Hook F (Tripterygium wilfordii Hook F)

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: UNKNOWN